Mechanistically, CD8+ T cell-derived IFNγ inhibits SLC7A11 expression in cancer cells through activating the transducer and activator of transcription 1 (STAT1), thereby inducing tumor cell ferroptosis and contributes to the anti-tumor efficacy of immunotherapy (Wang et al., 2019). This evidence concerns the gene CD8A and cancer.